Literature DB >> 7283414

Fluorimetric determination of cefuroxime in body fluids.

Z H Al-Rawi, S Tabaqchali.   

Abstract

A simple and accurate fluorimetric procedure for measuring cefuroxime in body fluids is described. A fluorescent product was produced by addition of hydrochloric acid, heating, and cooling, followed by addition of sodium hydroxide and further heating at 100 degree C. The fluorescence intensity of the final solution was measured in a fluorimeter at an excitation wavelength of 375 nm and an emission wavelength of 440 nm and related to the antibiotic concentration. Thin-layer chromatography of the final solution showed a single fluorescent spot (Rf value, 0.6). Freedom from interference from other therapeutic agents and endogenous substances, as well as the close correlation between this method and the standard microbiological assay method, was demonstrated. The simplicity and reliability of the fluorimetric assay method make it particularly suitable for clinical use.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283414      PMCID: PMC181626          DOI: 10.1128/AAC.20.1.25

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Fluorimetric determination of cephalexin.

Authors:  R H Barbhaiya; P Turner
Journal:  J Pharm Pharmacol       Date:  1976-10       Impact factor: 3.765

2.  Pharmacokinetic and clinical studies on cefuroxime.

Authors:  R Norrby; R D Foord; J D Price; P Hedlund
Journal:  Proc R Soc Med       Date:  1977

3.  Fluorometric determination of cephradine in plasma.

Authors:  A F Heald; C E Ita; E C Schreiber
Journal:  J Pharm Sci       Date:  1976-05       Impact factor: 3.534

4.  Fluorimetric assay of cephradine, cephalexin and cephaloglycin.

Authors:  R H Barbhaiya; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases.

Authors:  D Greenwood; N J Pearson; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1976-12       Impact factor: 5.790

6.  Concepts and practices in the evaluation of clinical chemistry methods. III: Statistics.

Authors:  J O Westgard; D J de Vos; M R Hunt; E F Quam; C C Garber; R N Carey
Journal:  Am J Med Technol       Date:  1978-06

7.  Cefuroxime, a new cephalosporin antibiotic: activity in vivo.

Authors:  D M Ryan; C O'Callaghan; P W Muggleton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

8.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

9.  Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

Authors:  M H Richmond; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

10.  Rapid sensitive fluorometric analysis of cephalosporin antibiotics.

Authors:  A B Yu; C H Nightingale; D R Flanagan
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

View more
  1 in total

1.  Recent analytical methods for cephalosporins in biological fluids.

Authors:  R D Toothaker; D S Wright; L A Pachla
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.